Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 5000.00 | 2808.68 | 7228.00 | 7049.00 | 1.0254 | 1.0381 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 5000.00 | 2808.68 | 6686.00 | 7049.00 | 0.9485 | 0.9219 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 6957.00 | 7049.00 | 0.9870 | 0.9803 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 5000.00 | 2808.68 | 6958.00 | 7049.00 | 0.9871 | 0.9805 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 5000.00 | 2808.68 | 2606.00 | 7049.00 | 0.3697 | -0.0549 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 5000.00 | 2808.68 | 7109.00 | 7049.00 | 1.0085 | 1.0128 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 5000.00 | 2808.68 | 7028.00 | 7049.00 | 0.9970 | 0.9955 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 5000.00 | 2808.68 | 7006.00 | 7049.00 | 0.9939 | 0.9908 |
| BT-20 | Lapatinib | 1 | uM | 9 | 5000.00 | 2808.68 | 6227.00 | 7049.00 | 0.8834 | 0.8217 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7396.00 | 7049.00 | 1.0492 | 1.0737 | |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 111.00 | 114.75 | 0.9673 | 0.9061 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 156.25 | 71.09 | 145.00 | 114.75 | 1.2636 | 1.8063 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 156.25 | 71.09 | 86.00 | 114.75 | 0.7495 | 0.3174 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 156.25 | 71.09 | 117.00 | 114.75 | 1.0196 | 1.0570 |
| BT-20 | Erlotinib | 1 | uM | 9 | 156.25 | 71.09 | 114.00 | 114.75 | 0.9935 | 0.9811 |
| BT-20 | Lapatinib | 10 | uM | 9 | 156.25 | 71.09 | 38.00 | 114.75 | 0.3312 | -0.5962 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 156.25 | 71.09 | 125.00 | 114.75 | 1.0893 | 1.2637 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 156.25 | 71.09 | 99.00 | 114.75 | 0.8628 | 0.6151 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 156.25 | 71.09 | 148.00 | 114.75 | 1.2898 | 1.8908 |
| BT-20 | Lapatinib | 1 | uM | 9 | 156.25 | 71.09 | 115.00 | 114.75 | 1.0022 | 1.0063 |
| BT-20 | Linsitinib | 10 | uM | 9 | 156.25 | 71.09 | 75.00 | 114.75 | 0.6536 | 0.0806 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 156.25 | 71.09 | 142.00 | 114.75 | 1.2375 | 1.7227 |
| BT-20 | Erlotinib | 10 | uM | 9 | 156.25 | 71.09 | 111.00 | 114.75 | 0.9673 | 0.9061 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 156.25 | 71.09 | 100.00 | 114.75 | 0.8715 | 0.6388 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 156.25 | 71.09 | 99.00 | 114.75 | 0.8628 | 0.6151 |